title: Lymph node evaluation as a colon cancer quality measure: a national hospital report card.
abstract: BACKGROUND
  Examination of 12 or more regional lymph nodes for colon cancer is associated with improved staging and survival, and the National Quality Forum recently endorsed lymph node examination for colon cancer as a quality surveillance measure. However, information regarding the extent of hospital compliance with the 12-node measure in the United States is lacking.
  
  
  METHODS
  From the National Cancer Data Base, 1296 hospitals that performed 156 789 colectomies in 1996-1997 and 2004-2005 were identified, and rates of hospital-level compliance (defined as examination of >or=12 nodes in >or=75% of patients) in these two time periods were compared. Multivariable models were developed to determine if hospital type, volume, or differences in case mix were associated with 12-node measure compliance. All statistical tests were two-sided.
  
  
  RESULTS
  In 1996-1997, 15% of hospitals were compliant with the 12-node measure; in 2004-2005 the percentage of compliant hospitals had increased to 38%. From 1996-1997 to 2004-2005, 12-node measure compliance increased at 980 hospitals, remained unchanged at 6 hospitals, and decreased at 310 hospitals. In 2004-2005, National Cancer Institute-designated Comprehensive Cancer Centers were more frequently compliant with the 12-node measure than other academic hospitals, Veterans' Administration hospitals, or community hospitals (78.1% versus 52.4%, 53.1%, and 33.7%, respectively, all P < .001), even after adjustment for differences in characteristics of the colon cancer patients at these hospitals.
  
  
  CONCLUSIONS
  This study provides a national report card of nearly 1300 hospitals showing that more than 60% of institutions failed to achieve a compliance benchmark for the 12-node measure. Considerable improvement is needed in colon cancer nodal evaluation in the United States.
authors.affiliation: Cancer Programs, American College of Surgeons, Chicago, IL 60611, USA. kbilimoria@facs.org
authors.forename: Karl Y
authors.initials: KY
authors.lastname: Bilimoria
authors.forename: David J
authors.initials: DJ
authors.lastname: Bentrem
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Stewart
authors.forename: Mark S
authors.initials: MS
authors.lastname: Talamonti
authors.forename: David P
authors.initials: DP
authors.lastname: Winchester
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Russell
authors.forename: Clifford Y
authors.initials: CY
authors.lastname: Ko
mesh_terms: D000368:Aged; D019985:Benchmarking / Q000706:statistics & numerical data*; D003082:Colectomy; D003110:Colonic Neoplasms / Q000473:pathology* / Q000601:surgery; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006761:Hospitals / Q000592:standards / Q000706:statistics & numerical data*; D006801:Humans; D016015:Logistic Models; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D014481:United States
references.citation: J Clin Oncol. 2007 Feb 1;25(4):463; author reply 463-4
references.pmid: 17264350
references.citation: Surg Endosc. 2007 Dec;21(12):2142-6
references.pmid: 17522917
references.citation: J Natl Compr Canc Netw. 2009 Sep;7(8):778-831
references.pmid: 19755046
references.citation: Arch Pathol Lab Med. 2000 Jul;124(7):958-65
references.pmid: 10888771
references.citation: J Natl Cancer Inst. 2005 Feb 2;97(3):219-25
references.pmid: 15687365
references.citation: Ann Surg Oncol. 2008 Mar;15(3):683-90
references.pmid: 18183467
references.citation: Cancer. 1998 Aug 15;83(4):666-72
references.pmid: 9708929
references.citation: J Clin Oncol. 2006 Aug 1;24(22):3570-5
references.pmid: 16877723
references.citation: J Am Coll Surg. 2008 Feb;206(2):247-54
references.pmid: 18222376
references.citation: Ann Surg. 2006 Dec;244(6):1003-11
references.pmid: 17122626
references.citation: Am J Surg Pathol. 2002 Feb;26(2):179-89
references.pmid: 11812939
references.citation: JAMA. 1998 Nov 18;280(19):1690-1
references.pmid: 9832001
references.citation: JAMA. 2008 Feb 27;299(8):896-7; author reply 897-8
references.pmid: 18314429
references.citation: Ann Surg Oncol. 2003 Jan-Feb;10(1):65-71
references.pmid: 12513963
references.citation: J Clin Oncol. 2003 Aug 1;21(15):2912-9
references.pmid: 12885809
references.citation: JAMA. 2007 Nov 14;298(18):2149-54
references.pmid: 18000198
references.citation: Ann Surg Oncol. 2003 Apr;10(3):213-8
references.pmid: 12679304
references.citation: JAMA. 2000 Dec 20;284(23):3028-35
references.pmid: 11122590
references.citation: Ann Surg. 2006 Oct;244(4):602-10
references.pmid: 16998369
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8706-12
references.pmid: 16314630
references.citation: J Surg Oncol. 2002 Oct;81(2):63-9
references.pmid: 12355405
references.citation: Dis Colon Rectum. 2008 Feb;51(2):154-61
references.pmid: 18172729
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: JAMA. 2007 Nov 14;298(18):2194-5
references.pmid: 18000205
references.citation: Oncologist. 2006 Oct;11(9):973-80
references.pmid: 17030637
references.citation: J Natl Cancer Inst. 2007 Mar 21;99(6):433-41
references.pmid: 17374833
references.citation: JAMA. 2008 Feb 27;299(8):896; author reply 897-8
references.pmid: 18314430
references.citation: Ann Surg. 2002 Apr;235(4):458-63
references.pmid: 11923600
references.citation: World J Surg. 2002 Mar;26(3):384-9
references.pmid: 11865379
references.citation: J Natl Cancer Inst. 2001 Apr 18;93(8):583-96
references.pmid: 11309435
references.citation: J Eval Clin Pract. 1999 Aug;5(3):269-81
references.pmid: 10461579